Munger Mode rating: 4 out of 5 — Buy. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Price used: about $188.65, the October 16 close as reported by MarketBeat. I found only that one source for the figure. The stock closed near $186 on October 15 after rising about 4.5% on the Q3 report. The market capitalization is roughly $89.7 billion on 475.5 million shares. Charlie: Marsh (formerly Marsh McLennan) is the world's largest insurance broker. It also owns a very large benefits and retirement consultancy and a respected management consulting firm. We like it. Brokerage is a business where a few giants stand between buyers and sellers of risk, collect a toll on every transaction, and need almost no physical capital to do it. Warren: The price is the issue, and for once it is not an extreme one. After a bad 2026, the stock trades near 17.5 times this year's adjusted earnings, below the low 20s it has long commanded. That is about what the business is worth, not a bargain.
Recent filings analysed: 8-K (2026-10-27), FWP (2026-10-20), 8-K (2026-10-15), 10-Q (2026-10-15).
Stock screener · Superinvestor 13F holdings · Analyst sentiment